TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ABLATION DEVICES MARKET, BY TECHNOLOGY
6.1. Overview
6.2. Thermal Ablation
6.3. Non-Thermal Ablation
7. GLOBAL ABLATION DEVICES MARKET, BY APPLICATION
7.1. Overview
7.2. Cancer
7.3. Cardiovascular
7.4. Ophthalmology
7.5. Gynecology
7.6. Urology
7.7. Orthopedics
7.8. Others
8. GLOBAL ABLATION DEVICES MARKET, BY FUNCTION
8.1. Overview
8.2. Automated/Robotic
8.3. Conventional
9. GLOBAL ABLATION DEVICES MARKET, BY PROCEDURE
9.1. Overview
9.2. Aesthetics-Skin Rejuvenation and Tightening
9.3. Aesthetics-Body Sculpting, Fat Reduction, And The Reduction in The Appearance of Cellulite
9.4. Benign Prostatic Hyperplasia
9.5. Transurethral Needle Ablation
9.6. Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation Of The Prostate
9.7. Stress Urinary Incontinence
9.8. Menorrhagia/Endometrial Ablation
9.9. Uterine Fibroids
9.10. Spinal Decompression and Denervation
9.11. Varicose Veins
9.12. Atrial Fibrillation
9.13. Tumor Ablation
9.14. Others
10. GLOBAL ABLATION DEVICES MARKET, BY REGION
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Ablation devices Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Ablation devices Market,
11.7. Key developments and Growth Strategies
11.7.1. New Technology Launch/Application Function
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. COMPANY PROFILES
12.1. BOSTON SCIENTIFIC CORPORATION
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Technologys Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Smith & Nephew PLC
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Technologys Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. ST. JUDE MEDICAL, INC..
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Technologys Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Medtronic PLC
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Technologys Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Johnson and Johnson
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Technologys Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. BTG PLC
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Technologys Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. AtriCure, Inc.
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Technologys Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Olympus Corporation.
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Technologys Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Conmed Corporation
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Technologys Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. AngioDynamics, Inc.
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Technologys Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Accuray Incorporated
12.11.1. Company Overview
12.11.2. Financial Overview
12.11.3. Technologys Offered
12.11.4. Key Developments
12.11.5. SWOT Analysis
12.11.6. Key Strategies
12.12. C.R. Bard, Inc.
12.12.1. Company Overview
12.12.2. Financial Overview
12.12.3. Technologys Offered
12.12.4. Key Developments
12.12.5. SWOT Analysis
12.12.6. Key Strategies
12.13. Varian Medical Systems, Inc.
12.13.1. Company Overview
12.13.2. Financial Overview
12.13.3. Technologys Offered
12.13.4. Key Developments
12.13.5. SWOT Analysis
12.13.6. Key Strategies
12.14. Elekta AB
12.14.1. Company Overview
12.14.2. Financial Overview
12.14.3. Technologys Offered
12.14.4. Key Developments
12.14.5. SWOT Analysis
12.14.6. Key Strategies
12.15. Misonix, Inc.
12.15.1. Company Overview
12.15.2. Financial Overview
12.15.3. Technologys Offered
12.15.4. Key Developments
12.15.5. SWOT Analysis
12.15.6. Key Strategies
12.16. Hologic, Inc.
12.16.1. Company Overview
12.16.2. Financial Overview
12.16.3. Technologys Offered
12.16.4. Key Developments
12.16.5. SWOT Analysis
12.16.6. Key Strategies
12.17. Stryker Corporation
12.17.1. Company Overview
12.17.2. Financial Overview
12.17.3. Technologys Offered
12.17.4. Key Developments
12.17.5. SWOT Analysis
12.17.6. Key Strategies
12.18. EDAP TMS S.A.
12.18.1. Company Overview
12.18.2. Financial Overview
12.18.3. Technologys Offered
12.18.4. Key Developments
12.18.5. SWOT Analysis
12.18.6. Key Strategies
12.19. Japan Lifeline Co.,Ltd.
12.19.1. Company Overview
12.19.2. Financial Overview
12.19.3. Technologys Offered
12.19.4. Key Developments
12.19.5. SWOT Analysis
12.19.6. Key Strategies
12.20. Halyard Health, Inc.
12.20.1. Company Overview
12.20.2. Financial Overview
12.20.3. Technologys Offered
12.20.4. Key Developments
12.20.5. SWOT Analysis
12.20.6. Key Strategies
12.21. Merit Medical Systems, Inc.
12.21.1. Company Overview
12.21.2. Financial Overview
12.21.3. Technologys Offered
12.21.4. Key Developments
12.21.5. SWOT Analysis
12.21.6. Key Strategies
12.22. Integra Lifesciences Holdings Corporation
12.22.1. Company Overview
12.22.2. Financial Overview
12.22.3. Technologys Offered
12.22.4. Key Developments
12.22.5. SWOT Analysis
12.22.6. Key Strategies
12.23. Abbott Laboratories
12.23.1. Company Overview
12.23.2. Financial Overview
12.23.3. Technologys Offered
12.23.4. Key Developments
12.23.5. SWOT Analysis
12.23.6. Key Strategies
12.24. Terumo Corporation
12.24.1. Company Overview
12.24.2. Financial Overview
12.24.3. Technologys Offered
12.24.4. Key Developments
12.24.5. SWOT Analysis
12.24.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ABLATION DEVICES MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL ABLATION DEVICES MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 11 NORTH AMERICA ABLATION DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 12 U.S. ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 13 U.S. ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 14 U.S. ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 15 U.S. ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 16 CANADA ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 17 CANADA ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 CANADA ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 19 CANADA ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 20 EUROPE ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 21 EUROPE ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 22 EUROPE ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 23 EUROPE ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 24 EUROPE ABLATION DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 25 GERMANY ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 26 GERMANY ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 GERMANY ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 28 GERMANY ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 29 FRANCE ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 30 FRANCE ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 FRANCE ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 32 FRANCE ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 33 ITALY ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 34 ITALY ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 ITALY ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 36 ITALY ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 37 SPAIN ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 38 SPAIN ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 39 SPAIN ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 40 SPAIN ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 41 U.K ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 42 U.K ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 43 U.K ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 44 U.K ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 45 REST OF EUROPE ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 46 REST OF EUROPE ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 REST OF EUROPE ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 48 REST OF EUROPE ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 49 ASIA PACIFIC ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 50 ASIA PACIFIC ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 51 ASIA PACIFIC ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 52 ASIA PACIFIC ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 53 ASIA PACIFIC ABLATION DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 54 JAPAN ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 55 JAPAN ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 56 JAPAN ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 57 JAPAN ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 58 CHINA ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 59 CHINA ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 60 CHINA ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 61 CHINA ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 62 INDIA ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 63 INDIA ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 64 INDIA ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 65 INDIA ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 66 AUSTRALIA ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 67 AUSTRALIA ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 68 AUSTRALIA ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 69 AUSTRALIA ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 70 SOUTH KOREA ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 71 SOUTH KOREA ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 72 SOUTH KOREA ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 73 SOUTH KOREA ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 74 REST OF ASIA-PACIFIC ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 75 REST OF ASIA-PACIFIC ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 76 REST OF ASIA-PACIFIC ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 77 REST OF ASIA-PACIFIC ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 78 REST OF WORLD ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 79 REST OF WORLD ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 80 REST OF WORLD ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 81 REST OF WORLD ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 82 REST OF WORLD ABLATION DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 83 MIDDLE EAST ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 84 MIDDLE EAST ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 85 MIDDLE EAST ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 86 MIDDLE EAST ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 87 AFRICA ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 88 AFRICA ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 89 AFRICA ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 90 AFRICA ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 91 LATIN AMERICA ABLATION DEVICES MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 92 LATIN AMERICA ABLATION DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 93 LATIN AMERICA ABLATION DEVICES MARKET, BY FUNCTION, 2018-2032 (USD BILLION)
TABLE 94 LATIN AMERICA ABLATION DEVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ABLATION DEVICES MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ABLATION DEVICES MARKET
FIGURE 4 GLOBAL ABLATION DEVICES MARKET, SHARE (%), BY TECHNOLOGY, 2022
FIGURE 5 GLOBAL ABLATION DEVICES MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL ABLATION DEVICES MARKET, SHARE (%), BY FUNCTION, 2022
FIGURE 7 GLOBAL ABLATION DEVICES MARKET, SHARE (%), BY PROCEDURE, 2022
FIGURE 8 GLOBAL ABLATION DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 NORTH AMERICA: ABLATION DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 EUROPE: ABLATION DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 ASIA-PACIFIC: ABLATION DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 REST OF THE WORLD: ABLATION DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 GLOBAL ABLATION DEVICES MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 14 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
FIGURE 16 SMITH & NEPHEW PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 SMITH & NEPHEW PLC: SWOT ANALYSIS
FIGURE 18 ST. JUDE MEDICAL, INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 ST. JUDE MEDICAL, INC..: SWOT ANALYSIS
FIGURE 20 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 MEDTRONIC PLC: SWOT ANALYSIS
FIGURE 22 JOHNSON AND JOHNSON.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 JOHNSON AND JOHNSON.: SWOT ANALYSIS
FIGURE 24 BTG PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BTG PLC: SWOT ANALYSIS
FIGURE 26 ATRICURE, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ATRICURE, INC.: SWOT ANALYSIS
FIGURE 28 OLYMPUS CORPORATION.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 OLYMPUS CORPORATION.: SWOT ANALYSIS
FIGURE 30 CONMED CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 CONMED CORPORATION: SWOT ANALYSIS
FIGURE 32 ANGIODYNAMICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 ANGIODYNAMICS, INC.: SWOT ANALYSIS
FIGURE 34 ACCURAY INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 ACCURAY INCORPORATED: SWOT ANALYSIS
FIGURE 36 C.R. BARD, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 C.R. BARD, INC.: SWOT ANALYSIS
FIGURE 38 VARIAN MEDICAL SYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 VARIAN MEDICAL SYSTEMS, INC.: SWOT ANALYSIS
FIGURE 40 ELEKTA AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 ELEKTA AB: SWOT ANALYSIS
FIGURE 42 MISONIX, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 MISONIX, INC.: SWOT ANALYSIS
FIGURE 44 HOLOGIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 45 HOLOGIC, INC.: SWOT ANALYSIS
FIGURE 46 STRYKER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 47 STRYKER CORPORATION: SWOT ANALYSIS
FIGURE 48 EDAP TMS S.A: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 49 EDAP TMS S.A: SWOT ANALYSIS
FIGURE 50 JAPAN LIFELINE CO.,LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 51 JAPAN LIFELINE CO.,LTD.: SWOT ANALYSIS
FIGURE 52 HALYARD HEALTH, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 53 HALYARD HEALTH, INC.: SWOT ANALYSIS
FIGURE 54 MERIT MEDICAL SYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 55 MERIT MEDICAL SYSTEMS, INC.: SWOT ANALYSIS
FIGURE 56 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 57 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: SWOT ANALYSIS
FIGURE 58 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 59 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 60 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 61 TERUMO CORPORATION: SWOT ANALYSIS
